newsfilter
← Latest News
Business Wire·

Graphite Bio Announces Pricing of Upsized Initial Public Offering

Graphite Bio, Inc., a clinical-stage, next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases, today announced the pricing of its upsized initial public offering of 14,000,000 sh